Clinical Trials

New Search
Title   Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Disease/Condition   Neuroblastoma
Eligibility Criteria   Ages Eligible for Study: up to 17 Months Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Peter Cole, MD
Contact Name   Joyce Brown
Phone   (718) 741-2356
Contact Email
IRB/Protocol Number   ANBL1232
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes